Index Change Advice - 20130708 Cipla Medpro Deletion
Cipla Medpro (South Africa): Constituent Deletion
FTSE/JSE Africa Index Series
3 July 2013
Subject to the completion of the scheme of arrangement, the proposed delisting of Cipla
Medpro (South Africa, constituent) and notification from the Stock Exchange, FTSE and
the JSE announces the following changes:
INDEX CHANGE EFFECTIVE FROM
START OF
TRADING
FTSE/JSE Africa Small Cap Cipla Medpro (South Africa, 8 July 2013
(J202) ZAE000128179, B09RFM8) will
be deleted from the index.
FTSE/JSE Africa All Share Cipla Medpro will be deleted from 8 July 2013
(J203) the index.
FTSE JSE RAFI All Share Cipla Medpro will be deleted from 8 July 2013
Index (J263) the index.
FTSE JSE RAFI All Share Cipla Medpro will be deleted from 8 July 2013
Capped Index (J283) the index.
FTSE/JSE Africa Capped All Cipla Medpro will be deleted from 8 July 2013
Share (J303) the index.
FTSE/JSE Africa Shareholder Cipla Medpro will be deleted from 8 July 2013
Weighted All Share (J403) the index.
FTSE/JSE Africa Style (J330 Cipla Medpro will be deleted from 8 July 2013
and J331) the index.
FTSE/JSE Africa All Share Cipla Medpro will be deleted from 8 July 2013
Shariah (J143) the index.
FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or
general enquiries please contact us at info@ftse.com or indices@jse.co.za or call:
Client Services in UK: Tel: +44 (0) 20 7866 1810
Client Services in Europe, Middle East & Tel: +44 (0) 20 7866 1810
Africa:
Client Services in US: Tel: +1 888 747 FTSE (3873) or +1 212 314 1139
Client Services in Asia Pacific: Tel: +852 2164 3333 or +65 6223 3738 or +81 3 3581 2811
JSE Limited: Tel: (+27 11) 520 7106 or + (+27 11) 520 7137
Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za
Terms of Use | Copyright © FTSE
Date: 03/07/2013 05:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.